logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Brii Biosciences-B (02137.HK) repurchased 62,500 shares for HK$62,300 on November 2.

date
02/11/2026
Zhitong Finance APP News, Brii Biosciences-B (02137.HK) announced that on November 2, 2026, the company spent HK$62,300 to repurchase 62,500 shares at a repurchase price of HK$0.99-1.005 per share.
Latest
2 m ago
Global Payments acquisition rumors spark valuation debate! "Big Short" Burry: The real opportunity lies in Fiserv (FISV.US) and PayPal (PYPL.US)
3 m ago
Dingdang Health (09886.HK) repurchased 805,500 shares for HKD 708,100 on November 2.
3 m ago
Hongxin Electronics (300657.SZ) plans to repurchase company shares for RMB 300 million to RMB 600 million.
4 m ago
HaidiLao (06862.HK) Controlling Shareholder Repays Loan Ahead of Schedule
4 m ago
CSPC Pharmaceutical Group (01093.HK): Phase III clinical trial of Prusogliptin Tablets combined with Dapagliflozin Tablets and Metformin Hydrochloride Extended-Release Tablets for the treatment of type 2 diabetes achieves positive topline results
See all latestmore
logo
Contact US
qr
+852 - 60190728
[email protected]
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.